346 related articles for article (PubMed ID: 30256818)
21. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
[TBL] [Abstract][Full Text] [Related]
22. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
[TBL] [Abstract][Full Text] [Related]
23. Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids.
Ostermann AI; Schebb NH
Food Funct; 2017 Jul; 8(7):2355-2367. PubMed ID: 28682409
[TBL] [Abstract][Full Text] [Related]
24. Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls.
van der Does AM; Heijink M; Mayboroda OA; Persson LJ; Aanerud M; Bakke P; Eagan TM; Hiemstra PS; Giera M
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):224-233. PubMed ID: 30528790
[TBL] [Abstract][Full Text] [Related]
25. Alcoholic Liver Disease: Update on the Role of Dietary Fat.
Kirpich IA; Miller ME; Cave MC; Joshi-Barve S; McClain CJ
Biomolecules; 2016 Jan; 6(1):1. PubMed ID: 26751488
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
Scorletti E; Byrne CD
Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
[TBL] [Abstract][Full Text] [Related]
27. Cyanidin-3-O-glucoside alleviates ethanol-induced liver injury by promoting mitophagy in a Gao-binge mouse model of alcohol-associated liver disease.
He Q; Yin Z; Chen Y; Wu Y; Pan D; Cui Y; Zhang Z; Ma H; Li X; Shen C; Qin J; Wang S
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167259. PubMed ID: 38796918
[TBL] [Abstract][Full Text] [Related]
28. Feeding mice a diet high in oxidized linoleic acid metabolites does not alter liver oxylipin concentrations.
Liang N; Hennebelle M; Gaul S; Johnson CD; Zhang Z; Kirpich IA; McClain CJ; Feldstein AE; Ramsden CE; Taha AY
Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102316. PubMed ID: 34403987
[TBL] [Abstract][Full Text] [Related]
29. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
Dasilva G; Medina I
Free Radic Biol Med; 2019 Nov; 144():90-109. PubMed ID: 30902758
[TBL] [Abstract][Full Text] [Related]
30. NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease.
Mainz RE; Albers S; Haque M; Sonntag R; Treichel NS; Clavel T; Latz E; Schneider KM; Trautwein C; Otto T
Cells; 2022 Jan; 11(2):. PubMed ID: 35053298
[TBL] [Abstract][Full Text] [Related]
31. The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.
Kim HG; Huang M; Xin Y; Zhang Y; Zhang X; Wang G; Liu S; Wan J; Ahmadi AR; Sun Z; Liangpunsakul S; Xiong X; Dong XC
J Hepatol; 2019 Nov; 71(5):960-969. PubMed ID: 31295533
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Scorletti E; Byrne CD
Annu Rev Nutr; 2013; 33():231-48. PubMed ID: 23862644
[TBL] [Abstract][Full Text] [Related]
33. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
[TBL] [Abstract][Full Text] [Related]
34. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
[TBL] [Abstract][Full Text] [Related]
35. S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver.
Yuan Q; Hou S; Zhai J; Tian T; Wu Y; Wu Z; He J; Chen Z; Zhang J
J Mol Med (Berl); 2019 Oct; 97(10):1399-1412. PubMed ID: 31321478
[TBL] [Abstract][Full Text] [Related]
36. Hepatic lipid profiling of deer mice fed ethanol using ¹H and ³¹P NMR spectroscopy: a dose-dependent subchronic study.
Fernando H; Bhopale KK; Boor PJ; Ansari GA; Kaphalia BS
Toxicol Appl Pharmacol; 2012 Nov; 264(3):361-9. PubMed ID: 22884994
[TBL] [Abstract][Full Text] [Related]
37. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.
Zabala V; Tong M; Yu R; Ramirez T; Yalcin EB; Balbo S; Silbermann E; Deochand C; Nunez K; Hecht S; de la Monte SM
Alcohol Alcohol; 2015 Mar; 50(2):118-31. PubMed ID: 25618784
[TBL] [Abstract][Full Text] [Related]
38. Dietary EPA and DHA prevent changes in white adipose tissue omega-3 PUFA and oxylipin content associated with a Fads2 deficiency.
Sarr O; Payne GW; Hucik B; Abdelmagid S; Nakamura MT; Ma DWL; Mutch DM
J Nutr Biochem; 2019 Jan; 63():140-149. PubMed ID: 30368227
[TBL] [Abstract][Full Text] [Related]
39. Inflammation is independent of steatosis in a murine model of steatohepatitis.
Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
[TBL] [Abstract][Full Text] [Related]
40. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease.
Assiri MA; Ali HR; Marentette JO; Yun Y; Liu J; Hirschey MD; Saba LM; Harris PS; Fritz KS
Hum Genomics; 2019 Dec; 13(1):65. PubMed ID: 31823815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
